HIMS GLP user forecast
Posted: Jul 01, 2024
- HIMS has approximately 1.6 million subscribers - Assuming 10% of their subscribers purchase GLPs at $1.99 per month, potential revenue could be $380 million annually - This estimate does not account for new subscribers or other products offered by HIMS - HIMS is forecasted to reach $1.2 billion in revenue by 2024 - With potential growth rates, the stock could see explosive numbers and go parabolic - Only a small percentage of obese Americans need to sign up for a product cheaper than competitors for significant growth - Despite criticism and short reports, strong financials could drive the stock price up - Consider this as a stock play for the second half of the year - Do your own research and happy 4th!
🚨 Reddit sentiment: mixed/positive - While there are mixed sentiments about the stock, most users are bullish about HIMS, especially with their new ventures into weight loss drugs and future earnings. Summarized comments: - A user deep dived into HIMS, mentioning their August earners analysis doesn't include recent ventures into weight loss drugs and expects the stock to hit $40/share in August after earnings - Some users believe the business model of HIMS is strong despite personal fears about the stock - There are mixed opinions about the effectiveness and consumer interest in non-FDA approved weight loss drugs - One user anticipates HIMS stock to significantly increase after earnings due to the weight loss venture - There's skepticism about the stock's value being already priced in - Some comments highlight personal or anecdotal evidence of the effectiveness of non-FDA approved semaglutides Stock tickers discussed: $HIMS
Stay ahead of the market with AI stock alerts & AI summaries of the latest earnings, stock ideas for free with Fluid Bot. Sign up now!